Madrigal Pharmaceuticals
MDGL
MDGL
32 hedge funds and large institutions have $23.6M invested in Madrigal Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.59% more ownership
Funds ownership: 11.63% → 13.22% (+1.6%)
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$772K | |
| 2 | +$770K | |
| 3 | +$486K | |
| 4 |
Goldman Sachs
New York
|
+$321K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$306K |
Top Sellers
| 1 | -$161K | |
| 2 | -$41.2K | |
| 3 | -$708 | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$538 |